165 related articles for article (PubMed ID: 8673041)
1. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation.
Talmadge JE; Reed EC; Kessinger A; Kuszynski CA; Perry GA; Gordy CL; Mills KC; Thomas ML; Pirruccello SJ; Letheby BA; Arneson MA; Jackson JD
Bone Marrow Transplant; 1996 Jan; 17(1):101-9. PubMed ID: 8673041
[TBL] [Abstract][Full Text] [Related]
2. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
[TBL] [Abstract][Full Text] [Related]
3. Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products.
Ageitos AG; Varney ML; Bierman PJ; Vose JM; Warkentin PI; Talmadge JE
Bone Marrow Transplant; 1999 Jan; 23(1):63-9. PubMed ID: 10037052
[TBL] [Abstract][Full Text] [Related]
4. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
5. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.
Talmadge JE; Reed E; Ino K; Kessinger A; Kuszynski C; Heimann D; Varney M; Jackson J; Vose JM; Bierman PJ
Bone Marrow Transplant; 1997 Jan; 19(2):161-72. PubMed ID: 9116614
[TBL] [Abstract][Full Text] [Related]
6. Restoration of T and NK cell function in GM-CSF mobilized stem cell products from breast cancer patients by monocyte depletion.
Ageitos AG; Ino K; Ozerol I; Tarantolo S; Heimann DG; Talmadge JE
Bone Marrow Transplant; 1997 Jul; 20(2):117-23. PubMed ID: 9244414
[TBL] [Abstract][Full Text] [Related]
7. GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expression.
Watanabe T; Dave B; Heimann DG; Lethaby E; Kessinger A; Talmadge JE
Bone Marrow Transplant; 1997 Jun; 19(12):1175-81. PubMed ID: 9208110
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
9. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[TBL] [Abstract][Full Text] [Related]
10. T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells.
Rondelli D; Anasetti C; Fortuna A; Ratta M; Arpinati M; Bandini G; Lemoli RM; Tura S
Bone Marrow Transplant; 1998 Jun; 21(12):1183-91. PubMed ID: 9674849
[TBL] [Abstract][Full Text] [Related]
11. Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
Bone Marrow Transplant; 1996 Dec; 18(6):1073-9. PubMed ID: 8971375
[TBL] [Abstract][Full Text] [Related]
12. Suppression of natural killer cells in the presence of CD34+ blood progenitor cells and peripheral blood lymphocytes.
Clausen J; Enk M; Vergeiner B; Eisendle K; Petzer AL; Gastl G; Gunsilius E
Biol Blood Marrow Transplant; 2004 Oct; 10(10):691-7. PubMed ID: 15389435
[TBL] [Abstract][Full Text] [Related]
13. [Kinetic study on the variety of lymphocytes and CD34+ cell subsets during autologous peripheral blood stem cell transplantation].
Han XH; Shi YK; He XH; Yang JL; Liu P
Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):47-50. PubMed ID: 12678987
[TBL] [Abstract][Full Text] [Related]
14. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory cytokines in bone marrow and peripheral blood stem cell products.
Singh RK; Ino K; Varney ML; Heimann DG; Talmadge JE
Bone Marrow Transplant; 1999 Jan; 23(1):53-62. PubMed ID: 10037051
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
Choi D; Perrin M; Hoffmann S; Chang AE; Ratanatharathorn V; Uberti J; McDonagh KT; Mulé JJ
Clin Cancer Res; 1998 Nov; 4(11):2709-16. PubMed ID: 9829733
[TBL] [Abstract][Full Text] [Related]
18. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
20. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]